Target intelligence / Profile preview

Non-Versican messenger RNAs (Non-VCAN mRNAs)

Target
Non-VCAN mRNAs
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

Non-VCAN mRNAs refers to the collective set of messenger RNA transcripts within a cell that do not encode the Versican (VCAN) protein. This term is not a specific therapeutic target but rather a category used in the context of RNA-targeted drug discovery, such as antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs), to define the off-target landscape. Versican is a critical extracellular matrix proteoglycan involved in cell adhesion, proliferation, and migration, and its dysregulation is linked to cancer, cardiovascular disease, and inflammation (UniProt P13611). When designing therapies to modulate VCAN, it is essential to ensure high specificity to avoid binding to non-VCAN mRNAs, which could lead to unintended gene silencing and cellular toxicity (Nature Reviews Drug Discovery, 2020). Consequently, non-VCAN mRNAs represent the negative selection criteria used during bioinformatics screening and lead optimization to ensure drug safety and minimize side effects.

Other names
Off-target mRNAsNon-specific transcriptsCellular transcriptome excluding VCANNon-VCAN transcripts
02

Mechanism of action

Not applicable as this is a collective group of non-target molecules defined by the absence of a specific sequence.

03

Biological functions

Protein synthesisGenetic information transferCellular homeostasis
04

Disease associations

Other
05

Safety considerations

Off-target effectsUnintended gene silencingTranscriptome-wide toxicityCross-reactivity

Beyond the preview

Go deeper on Non-Versican messenger RNAs (Non-VCAN mRNAs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-Versican messenger RNAs (Non-VCAN mRNAs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call